Thoracic Surgery Branch: Clinical Trials
-
Phase I/II Evaluation of Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients with Inoperable or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and
Open - RecruitingNCI Protocol ID NCI-17-C-0140Investigator David S. Schrump, M.D., M.B.A. -
Phase I/II Evaluation of Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in Patients with Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms with Pleuropulmonary Metastases
Open - RecruitingNCI Protocol ID NCI-16-C-0152Investigator David S. Schrump, M.D., M.B.A. -
Prospective Evaluation of Genetic and Epigenetic Alterations in Patients with Thoracic Malignancies
Open - RecruitingNCI Protocol ID NCI-06-C-0014Investigator David S. Schrump, M.D., M.B.A.